Literature DB >> 23860358

Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history.

Jennifer L Marino1, Christobel M Saunders, Laura I Emery, Helena Green, Dorota A Doherty, Martha Hickey.   

Abstract

OBJECTIVE: After cancer treatment, troublesome menopausal symptoms are common but poorly understood. Using standardized instruments, we measured differences in symptom nature, severity, impact on quality of life, and sexual function between cancer survivors and noncancer participants.
METHODS: The Menopause Symptoms After Cancer Clinic operates within the general menopause service in a large women's hospital, providing menopause advice and management to women with menopausal symptoms and a cancer history. Menopausal symptoms were recorded using the Greene Climacteric Scale, past-week symptoms were recorded using the Functional Assessment of Cancer Therapy breast cancer subscale and endocrine symptom subscale, and sexual symptoms were recorded using Fallowfield's Sexual Activity Questionnaire.
RESULTS: Cancer survivors (n = 934) and noncancer participants (n = 155) did not significantly differ by age at menopause (46 y) or age at first clinic visit (51 y). Cancer survivors were more likely than noncancer participants to be severely troubled by vasomotor symptoms (hot flushes and night sweats; odds ratio, 1.71; 95% CI, 1.06-2.74) and reported more frequent (6.0 vs 3.1 in 24 h; P < 0.001) and more severe (P = 0.008) hot flushes. In contrast, cancer survivors were significantly less troubled by psychological and somatic symptoms and reported better quality of life than noncancer participants. Groups did not differ significantly in physical or functional well-being, gynecologic symptom severity, or sexual function.
CONCLUSIONS: Cancer survivors are more troubled by vasomotor symptoms than noncancer participants, but noncancer participants report greater psychological symptoms. Sexual function does not differ. An improved understanding of the nature and impact of menopause on cancer survivors can be used to direct management protocols.

Entities:  

Mesh:

Year:  2014        PMID: 23860358     DOI: 10.1097/GME.0b013e3182976f46

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  13 in total

1.  Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Authors:  Debra L Barton; Kelliann C Fee Schroeder; Tanima Banerjee; Sherry Wolf; Timothy Z Keith; Gary Elkins
Journal:  Menopause       Date:  2017-07       Impact factor: 2.953

2.  Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors.

Authors:  Tera L Fazzino; Jennifer Klemp; Christie Befort
Journal:  Breast Cancer Res Treat       Date:  2017-12-22       Impact factor: 4.872

Review 3.  Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.

Authors:  Claire Johns; Susan M Seav; Sally A Dominick; Jessica R Gorman; Hongying Li; Loki Natarajan; Jun James Mao; H Irene Su
Journal:  Breast Cancer Res Treat       Date:  2016-03-26       Impact factor: 4.872

4.  Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.

Authors:  Michelle Peate; Christobel Saunders; Paul Cohen; Martha Hickey
Journal:  Breast Cancer Res Treat       Date:  2021-02-11       Impact factor: 4.872

5.  The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview.

Authors:  Cheryl Phua; Rodney Baber
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

6.  Qualitative assessment of information and decision support needs for managing menopausal symptoms after breast cancer.

Authors:  Lynda G Balneaves; Dimitra Panagiotoglou; Alison S A Brazier; Leah K Lambert; Antony Porcino; Margaret Forbes; Cheri Van Patten; Tracy L O Truant; Dugald Seely; Dawn Stacey
Journal:  Support Care Cancer       Date:  2016-06-08       Impact factor: 3.603

7.  Factors related to the experience of menopausal symptoms in women prescribed tamoxifen.

Authors:  Zoe Moon; Myra S Hunter; Rona Moss-Morris; Lyndsay Dawn Hughes
Journal:  J Psychosom Obstet Gynaecol       Date:  2016-09-01       Impact factor: 2.949

8.  The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT.

Authors:  Lesley Fallowfield; Ivonne Solis-Trapala; Usha Menon; Carolyn Langridge; Shirley May; Ian Jacobs; Valerie Jenkins
Journal:  Br J Cancer       Date:  2017-03-21       Impact factor: 7.640

9.  The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer.

Authors:  Marta Capelan; Nicolò Matteo Luca Battisti; Anne McLoughlin; Vivienne Maidens; Nikki Snuggs; Patrycja Slyk; Clare Peckitt; Alistair Ring
Journal:  Br J Cancer       Date:  2017-08-31       Impact factor: 7.640

Review 10.  Nonhormonal Hot Flash Management for Breast Cancer Survivors: A Systematic Review and Network Meta-Analysis.

Authors:  Jian Liu; Guangning Nie; Yang Li; Zehuai Wen; Liming Lu; Li Xie; Dongdong Cao; Yafang Lai; Hongyan Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.